FDA Approves HeadOff,™ A Breakthrough Treatment For Headaches

NEW YORK –– The U.S. Food and Drug Administration has given an official thumbs up to HeadOff,™ a new medication developed by Pfizer to treat adults with chronic headaches. Delivered in a series of explosive doses, HeadOff™ provides complete and permanent relief from symptoms occurring above the neck.

According to its label, the drug can be taken orally—u…